Recombinational cloning using nucleic acids having recombination sites
View Patent ↗Recombinational cloning is provided by the use of nucleic acids, vectors and methods, in vitro and in vivo, for moving or exchanging segments of DNA molecules using engineered recombination sites and recombination proteins to provide chimeric DNA molecules that have the desired characteristic(s) and/or DNA segment(s).
1. A composition, outside of a cell, comprising:
(a) a first isolated nucleic acid molecule having one or more lox recombination sites and one or more topoisomerase recognition sites;
(b) a second isolated nucleic acid molecule having two or more lox recombination sites and two or more topoisomerase recognition sites; and
(c) a topoisomerase.
2. The composition of claim 1 , wherein the lox sites are selected from the group consisting of loxP and loxP511.
3. The composition of claim 1 , wherein at least one of the one or more lox recombination sites of the first isolated nucleic acid molecule may recombine with at least two of the two or more lox recombination sites of the second isolated nucleic acid molecule.
4. The composition of claim 1 , wherein at least two of the two or more lox recombination sites of the second isolated nucleic acid molecule flank at least two of the two or more topoisomerase recognition sites.
5. The composition of claim 1 , wherein the topoisomerase is a type I topoisomerase.
6. The composition of claim 1 , wherein the two or more topoisomerase recognition sites are recognized by a type I topoisomerase.
7. The composition of claim 1 , wherein the topoisomerase is bound to the first isolated nucleic acid molecule.
8. The composition of claim 1 , wherein the second isolated nucleic acid molecule further comprises an origin of replication.
9. The composition of claim 1 , wherein the second isolated nucleic acid molecule further comprises a selectable marker.
10. The composition of claim 9 , wherein the selectable marker is an antibiotic resistance gene.
11. A composition, outside of a cell, comprising:
(a) an isolated nucleic acid molecule having one or more lox recombination sites; and
(b) one or more topoisomerases bound to the isolated nucleic acid molecule.
12. The composition of claim 11 further comprising a second isolated nucleic acid molecule having two or more lox recombination sites and two or more topoisomerase recognition sites.
13. The composition of claim 12 , wherein the lox sites are selected from the group consisting of loxP and loxP511.
14. The composition of claim 12 , wherein at least one of the one or more lox recombination sites of the first isolated nucleic acid molecule may recombine with at least two of the two or more lox recombination sites of the second isolated nucleic acid molecule.
15. The composition of claim 12 , wherein at least two of the two or more lox recombination sites of the second isolated nucleic acid molecule flank at least two of the two or more topoisomerase recognition sites.
16. The composition of claim 12 , wherein the topoisomerase is a type I topoisomerase.
17. The composition of claim 12 , wherein the two or more topoisomerase recognition sites are recognized by a type I topoisomerase.
18. The composition of claim 12 , wherein the second isolated nucleic acid molecule further comprises an origin of replication.
19. The composition of claim 12 , wherein the second isolated nucleic acid molecule further comprises a selectable marker.
20. The composition of claim 19 , wherein the selectable marker is an antibiotic resistance gene.